UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience

The World Allergy Organization journal, 2019-01, Vol.12 (4), p.100032, Article 100032

2019

Volltextzugriff (PDF)

Relevance of TH2 Markers in the Assessment and Therapeutic Management of Severe Allergic Asthma: A Real-Life Perspective

Journal of investigational allergology & clinical immunology, 2020, Vol.30 (1), p.35-41

2020

Volltextzugriff (PDF)

Severe asthma management in the era of biologics: insights of the Italian Registry on Severe Asthma (IRSA)

European annals of allergy and clinical immunology, 2021-05, Vol.53 (3), p.103

2021

Volltextzugriff (PDF)

Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience

BMC pulmonary medicine, 2016-08, Vol.16 (1), p.128-128, Article 128

2016

Volltextzugriff (PDF)

Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program

International journal of chronic obstructive pulmonary disease, 2019-01, Vol.14, p.645-657

2019

Volltextzugriff (PDF)

Comprehensive effects of supplemented essential amino acids in patients with severe COPD and sarcopenia

Monaldi archives for chest disease, 2010-03, Vol.73 (1), p.25-33

2010

Volltextzugriff (PDF)

Costs of chronic obstructive pulmonary disease (COPD) in Italy: The SIRIO study (Social Impact of Respiratory Integrated Outcomes)

Respiratory medicine, 2008-01, Vol.102 (1), p.92-101

2008

Volltextzugriff (PDF)

Essential amino acid supplementation in patients with severe COPD: a step towards home rehabilitation

Monaldi archives for chest disease, 2012-06, Vol.77 (2), p.67-75

2012

Volltextzugriff (PDF)

Essential amino acid supplementation in patients with severe COPD: a step towards home rehabilitation

Monaldi archives for chest disease, 2015-12, Vol.77 (2)

2015

Volltextzugriff (PDF)

Erdosteine affects eicosanoid production in COPD

International journal of clinical pharmacology and therapeutics, 2011-01, Vol.49 (1), p.41-45

2011

Volltextzugriff (PDF)

Changes in blood ROS, e-NO, and some pro-inflammatory mediators in bronchial secretions following erdosteine or placebo: A controlled study in current smokers with mild COPD

Pulmonary pharmacology & therapeutics, 2008-01, Vol.21 (2), p.304-308

2008

Volltextzugriff (PDF)

Use of aerosols in bronchiectasis patients

Monaldi archives for chest disease, 2011-09, Vol.75 (3), p.185-193

2011

Volltextzugriff (PDF)

Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA‐sensitive asthmatics: a controlled study vs placebo

Allergy (Copenhagen), 2004-03, Vol.59 (3), p.289-294

2004

Volltextzugriff (PDF)

Changes of clinical outcomes and health care resources in moderate and in severe COPD treated uniquely with tiotropium 18 mcg od for twenty-four months

Pulmonary pharmacology & therapeutics, 2011-08, Vol.24 (4), p.373-376

2011

Volltextzugriff (PDF)

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts

British Journal of Cancer, 1999-08, Vol.80 (12), p.1912-1919

1999

Volltextzugriff (PDF)

Reference urinary LTE4 levels in normal individuals: a pilot study

European annals of allergy and clinical immunology, 2011-02, Vol.43 (1), p.22

2011

Volltextzugriff (PDF)

The prevalence of nasal polyps and the corresponding urinary LTE4 levels in severe compared to mild and moderate asthma

European annals of allergy and clinical immunology, 2010-06, Vol.42 (3), p.120

2010

Volltextzugriff (PDF)

PIKO-1, an effective, handy device for the patient's personal PEFR and FEV1 electronic long-term monitoring

Monaldi archives for chest disease, 2007-06, Vol.67 (2), p.84-89

2007

Volltextzugriff (PDF)

Cost-of-illness of lung disease in the TriVeneto Region, Italy: the GOLD Study

Monaldi archives for chest disease, 2002-02, Vol.57 (1), p.3

2002

Volltextzugriff (PDF)

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Journal of translational medicine, 2020-10, Vol.18 (1), p.405-405, Article 405

2020

Volltextzugriff (PDF)

Nimesulide : new clinical opportunities

Drugs (Basel), 1993, Vol.46 (Supplement 1), p.275-276

TOGNELLA, S

1993

Volltextzugriff (PDF)

Assessment of inhaled BDP‐dose dependency of exhaled nitric oxide and local and serum eosinophilic markers in steroids‐naive nonatopic asthmatics

Allergy (Copenhagen), 2003-10, Vol.58 (10), p.1018-1022

2003

Volltextzugriff (PDF)

Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study

The European respiratory journal, 2017-10, Vol.50 (4), p.1700711-1700711

2017

Volltextzugriff (PDF)

Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy

Journal of asthma and allergy, 2021-01, Vol.14, p.1011-1018

2021

Volltextzugriff (PDF)

An international randomized study of a home-based self-management program for severe COPD: the COMET

International journal of chronic obstructive pulmonary disease, 2016-01, Vol.11 (1), p.1447-1451

2016

Volltextzugriff (PDF)

1 – 25 von 250

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(182)
Mit Volltextzugriff
(142)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience

Relevance of TH2 Markers in the Assessment and Therapeutic Management of Severe Allergic Asthma: A Real-Life Perspective

Severe asthma management in the era of biologics: insights of the Italian Registry on Severe Asthma (IRSA)

Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience

Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program

Comprehensive effects of supplemented essential amino acids in patients with severe COPD and sarcopenia

Costs of chronic obstructive pulmonary disease (COPD) in Italy: The SIRIO study (Social Impact of Respiratory Integrated Outcomes)

Essential amino acid supplementation in patients with severe COPD: a step towards home rehabilitation

Essential amino acid supplementation in patients with severe COPD: a step towards home rehabilitation

Erdosteine affects eicosanoid production in COPD

Changes in blood ROS, e-NO, and some pro-inflammatory mediators in bronchial secretions following erdosteine or placebo: A controlled study in current smokers with mild COPD

Use of aerosols in bronchiectasis patients

Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA‐sensitive asthmatics: a controlled study vs placebo

Changes of clinical outcomes and health care resources in moderate and in severe COPD treated uniquely with tiotropium 18 mcg od for twenty-four months

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts

Reference urinary LTE4 levels in normal individuals: a pilot study

The prevalence of nasal polyps and the corresponding urinary LTE4 levels in severe compared to mild and moderate asthma

PIKO-1, an effective, handy device for the patient's personal PEFR and FEV1 electronic long-term monitoring

Cost-of-illness of lung disease in the TriVeneto Region, Italy: the GOLD Study

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Nimesulide : new clinical opportunities

Assessment of inhaled BDP‐dose dependency of exhaled nitric oxide and local and serum eosinophilic markers in steroids‐naive nonatopic asthmatics

Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study

Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy

An international randomized study of a home-based self-management program for severe COPD: the COMET

Suchergebnisse filtern